Cargando…
CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential
Lung cancer is the second most common malignancy and the leading cause of cancer-related death in the western world. Moreover, despite advances in surgery, chemotherapy and radiotherapy, the death rate from lung cancer remains high and the reported overall five-year survival rate is only 15%. Thus,...
Autores principales: | Wald, Ori, Shapira, Oz M., Izhar, Uzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563078/ https://www.ncbi.nlm.nih.gov/pubmed/23382783 http://dx.doi.org/10.7150/thno.4922 |
Ejemplares similares
-
CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)
por: Wald, Ori
Publicado: (2018) -
Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression
por: Kirshberg, Sophie, et al.
Publicado: (2011) -
Paraganglioma of the mediastinum: challenges in diagnosis and surgical management
por: Wald, Ori, et al.
Publicado: (2010) -
Outcomes of sublobar resection vs lobectomy for invasive clinical stage T1N0 non‐small‐cell lung cancer: A propensity‐match analysis
por: Wald, Ori, et al.
Publicado: (2021) -
CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018)